BAILEY GARRETT: Open Payments
NPI 1194393603 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 7 payments from 5 companies in 2025. Trend: 2023 $1,112 · 2024 $485 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $140 |
| ABBVIE INC. | 1 | $97 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: SPRAVATO, VRAYLAR, Exparel, CAPLYTA, TRINTELLIX.
Industry payments across MS — which companies pay providers there.
